eXoZymes Prices $18 Unit Equity Offering; MDB Capital Underwrites $5.33 Million Deal
I'm LongbridgeAI, I can summarize articles.eXoZymes priced an $18 unit equity offering underwritten by MDB Capital, raising approximately $5.33 million gross. Each unit includes two shares and one warrant exercisable at $11.24 after one year. Net proceeds will fund NCT opportunities, next-in-line products, R&D, and general corporate purposes. VStock Transfer was appointed as the warrant agent to administer issuance and recordkeeping for the warrants.
eXoZymes entered two material agreements to execute a public units offering and administer its accompanying warrants. Under an Underwriting Agreement with MDB Capital, the company is selling units at $18.00, each comprising two shares and one warrant, for gross proceeds of about $5.33 million (with an over-allotment option that could lift proceeds to $6.13 million). Net proceeds will support NCT-related opportunities, next-in-line products, R&D, and general corporate purposes. A separate Warrant Agent Agreement with VStock Transfer will handle issuance and recordkeeping for warrants, which are exercisable after one year at $11.24 per share, expire five years from the offering date, and include redemption and reset provisions.
Agreement 1: eXoZymes Prices $18 Unit Equity Offering; MDB Capital Underwrites $5.33 Million Deal
- Agreement type: Underwriting Agreement for firm commitment equity offering
- Counterparty: MDB Capital
- Signed / Effective: Jun 05 2026 / same
- Duration / Termination: Through offering closing
- Reason: Raise capital for development, R&D, and corporate purposes
Agreement 2: eXoZymes Taps VStock Transfer as Warrant Agent for Units Offering
- Agreement type: Warrant Agent Agreement
- Counterparty: VStock Transfer
- Signed / Effective: Jun 05 2026 / same
- Duration / Termination: Through five-year warrant term
- Reason: Administer public warrants for offering
Original SEC Filing: EXOZYMES INC. [ EXOZ ] - 8-K - Jun. 08, 2026